Cytek Biosciences (CTKB) Non Operating Investment Income (2022 - 2026)
Cytek Biosciences (CTKB) posted Non Operating Investment Income of -$201000.0 for Q1 2026, down 628.95% on a QoQ basis from $38000.0 in Q4 2025, and down 209.23% year-over-year from $184014.1 in Q1 2025.
Cytek Biosciences (CTKB) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Cytek Biosciences' Non Operating Investment Income history runs 5 years deep, the most recent figure standing at -$201000.0 for Q1 2026.
- Quarterly Non Operating Investment Income fell 209.23% year-over-year to -$201000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78000.0 (down 216.42% YoY) and the FY2025 annual result came in at $58000.0, down 40.21% from the prior year.
- Non Operating Investment Income was -$201000.0 for Q1 2026 at Cytek Biosciences, down from $38000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $195000.0 in Q3 2024 and bottomed at -$201000.0 in Q1 2026.
- A 5-year average of -$4071.4 and a median of -$9500.0 in 2023 frame the typical range for Non Operating Investment Income.
- Peak annual rise in Non Operating Investment Income reached 1200.0% in 2024, while the deepest fall reached 1466.67% in 2024.
- Cytek Biosciences' Non Operating Investment Income stood at $17000.0 in 2022, then slumped by 117.65% to -$3000.0 in 2023, then sank by 1466.67% to -$47000.0 in 2024, then surged by 180.85% to $38000.0 in 2025, then plunged by 628.95% to -$201000.0 in 2026.
- Business Quant data shows CTKB's Non Operating Investment Income at -$201000.0 in Q1 2026, $38000.0 in Q4 2025, and $118000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn | -201,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |